The Journal of Practical Medicine >
Progress of non-pharmacological treatments for treatment-resistant depression
Received date: 2023-10-12
Online published: 2024-03-08
Depression， with its characteristics of high prevalence， younger onset age， and high suicide rate， has repeatedly become the focus of societal discussion. It severely impairs the quality of life of patients and affects the development of the economy. Currently， treatments for depression are limited and vary in effectiveness. An increasing number of patients are classified as having treatment-resistant depression. In order to improve the cure rate further， numerous non-pharmacological treatments have been explored， among which physical therapies have garnered significant attention. This article provides a brief overview and discussion of recent physical treatments for treatment-resistant depression， offering new prospects for the field and inspiring readers with fresh ideas.
Rui XU , Xingbing. HUANG . Progress of non-pharmacological treatments for treatment-resistant depression[J]. The Journal of Practical Medicine, 2024 , 40(4) : 439 -446 . DOI: 10.3969/j.issn.1006-5725.2024.04.001
| 1 | MALHI G S， MANN J J. Depression［J］. Lancet （London， England）， 2018， 392（10161）： 2299-2312. doi:10.1016/s0140-6736(18)31948-2 |
| 2 | BERMAN R M， NARASIMHAN M， CHARNEY D S. Treatment-refractory depression： definitions and characteristics［J］. Depress Anxiety， 1997， 5（4）： 154-164. doi:10.1002/(sici)1520-6394(1997)5:4<154::aid-da2>3.0.co;2-d |
| 3 | 李凌江，马辛. 中国抑郁障碍防治指南［M］. 北京：中华医学电子音像出版社， 2015： 234. |
| 4 | RYBAK Y E， LAI K S P， RAMASUBBU R， et al. Treatment-resistant major depressive disorder： Canadian expert consensus on definition and assessment［J］. Depress Anxiety， 2021， 38（4）： 456-467. doi:10.1002/da.23135 |
| 5 | 安旭光，杨程皓. 难治性抑郁症的分级方法［J］. 四川精神卫生， 2016，29（6）： 583-586. doi:10.11886/j.issn.1007-3256.2016.06.021 |
| 6 | VOINESKOS D， DASKALAKIS Z J， BLUMBERGER D M. Management of Treatment-Resistant Depression： Challenges and Strategies［J］. Neuropsychiatr Dis Treat， 2020， 16： 221-234. doi:10.2147/ndt.s198774 |
| 7 | GBYL K， ROSTRUP E， RAGHAVA J M， et al. Volume of hippocampal subregions and clinical improvement following electroconvulsive therapy in patients with depression［J］. Prog NeuroPsychopharmacol Biol Psychiatry， 2021， 104： 110048. doi:10.1016/j.pnpbp.2020.110048 |
| 8 | MESHKAT S， ALNEFEESI Y， JAWAD M Y， et al. Brain-Derived Neurotrophic Factor （BDNF） as a biomarker of treatment response in patients with Treatment Resistant Depression （TRD）： A systematic review & meta-analysis［J］. Psychiatry Res， 2022， 317： 114857. doi:10.1016/j.psychres.2022.114857 |
| 9 | ARGYELAN M， OLTEDAL L， DENG Z D， et al. Electric field causes volumetric changes in the human brain［J］. eLife， 2019， 8： e49115. doi:10.7554/elife.49115 |
| 10 | FRIDGEIRSSON E A， DENG Z D， DENYS D， et al. Electric field strength induced by electroconvulsive therapy is associated with clinical outcome［J］. Neuro Image Clin， 2021， 30： 102581. doi:10.1016/j.nicl.2021.102581 |
| 11 | DOMINIAK M， ANTOSIK-WóJCI?SKA A Z， GOETZ Z， et al. Efficacy， safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression： A randomized open label controlled trial［J］. J Psychiatr Res， 2021， 133： 52-59. doi:10.1016/j.jpsychires.2020.12.002 |
| 12 | MUTZ J， VIPULANANTHAN V， CARTER B， et al. Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults： systematic review and network meta-analysis［J］. BMJ， 2019， 364： l1079. doi:10.1136/bmj.l1079 |
| 13 | REGENOLD W T， NOORANI R J， PIEZ D， et al. Nonconvulsive Electrotherapy for Treatment Resistant Unipolar and Bipolar Major Depressive Disorder： A Proof-of-concept Trial［J］. Brain Stimul， 2015， 8（5）： 855-861. doi:10.1016/j.brs.2015.06.011 |
| 14 | ZHENG W， JIANG M L， HE H B， et al. A Preliminary Study of Adjunctive Nonconvulsive Electrotherapy for Treatment-Refractory Depression［J］. Psychiatr Q， 2021， 92（1）： 311-320. doi:10.1007/s11126-020-09798-3 |
| 15 | YOON I Y， RYU J H， DO S H， et al. Etomidate versus Propofol for Electroconvulsive Therapy in Patients with Major Depressive Disorders in Terms of Clinical Responses to Treatment： A Retrospective Analysis［J］. Brain Sci， 2023， 13（7）： 1023. doi:10.3390/brainsci13071023 |
| 16 | LI K J， SLAMA N E， HIRSCHTRITT M E， et al. Electroconvulsive Therapy Anesthetic Choice and Clinical Outcomes［J］. J ECT， 2023， 39（2）： 102-105. doi:10.1097/yct.0000000000000895 |
| 17 | GONZALEZ S， VASAVADA M， NJAU S， et al. Acute changes in cerebral blood flow after single-infusion ketamine in major depression： a pilot study［J］. Neurol Psychiatry Brain Res， 2020， 38： 5-11. doi:10.1016/j.npbr.2020.08.006 |
| 18 | MODIR H， MAHMOODIYEH B， SHAYGANFARD M， et al. Efficacy of ketamine， propofol， and dexmedetomidine for anesthesia in electroconvulsive therapy in treatment-resistant major depressive disorder patients： a double-blind randomized clinical trial［J］. Med Gas Res， 2023， 13（3）： 112-117. doi:10.4103/2045-9912.350860 |
| 19 | WOOLSEY A J， NANJI J A， MOREAU C， et al. Low-dose ketamine does not improve the speed of recovery from depression in electroconvulsive therapy： a randomized controlled trial［J］. Braz J Psychiatry， 2022， 44（1）： 6-14. doi:10.1590/1516-4446-2020-1705 |
| 20 | 陈运良，熊朝晖，王晓斌，等. 小剂量氯胺酮复合丙泊酚麻醉对电休克抽搐发作的影响［J］. 实用医学杂志， 2013，29（3）： 459-461. doi:10.3969/j.issn.1006-5725.2013.03.046 |
| 21 | 黄兴兵，梅芳，黄雄，等. 不同麻醉剂无抽搐电休克治疗难治性抑郁症的疗效比较［J］. 实用医学杂志， 2015，31（17）：2808-2811. doi:10.3969/j.issn.1006-5725.2015.17.014 |
| 22 | MEMON R I， NAVEED S， FAQUIH A E， et al. Effectiveness and Safety of Ketamine for Unipolar Depression： a Systematic Review［J］. Psychiatr Q， 2020， 91（4）： 1147-1192. doi:10.1007/s11126-020-09830-6 |
| 23 | MOLERO P， RAMOS-QUIROGA J A， MARTIN-SANTOS R， et al. Antidepressant Efficacy and Tolerability of Ketamine and Esketamine： A Critical Review［J］. CNS Drugs， 2018， 32（5）： 411-420. doi:10.1007/s40263-018-0519-3 |
| 24 | SARTORIUS A， BEUSCHLEIN J， REMENNIK D， et al. Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure quality［J］. Eur Arch Psychiatry Clin Neurosci， 2021， 271（3）： 457-463. doi:10.1007/s00406-020-01170-7 |
| 25 | ROSSON S， DE FILIPPIS R， CROATTO G， et al. Brain stimulation and other biological non-pharmacological interventions in mental disorders： An umbrella review［J］. Neurosci Biobehav Rev， 2022， 139： 104743. doi:10.1016/j.neubiorev.2022.104743 |
| 26 | KAYSER S， BEWERNICK B H， GRUBERT C， et al. Antidepressant effects， of magnetic seizure therapy and electroconvulsive therapy， in treatment-resistant depression［J］. J Psychiatr Res， 2011， 45（5）： 569-576. doi:10.1016/j.jpsychires.2010.09.008 |
| 27 | CHEN M， YANG X， LIU C， et al. Comparative efficacy and cognitive function of magnetic seizure therapy vs. electroconvulsive therapy for major depressive disorder： a systematic review and meta-analysis［J］. Transll Psychiatry， 2021， 11（1）： 437. doi:10.1038/s41398-021-01560-y |
| 28 | WEISSMAN C R， BLUMBERGER D M， DIMITROVA J， et al. Magnetic Seizure Therapy for Suicidality in Treatment-Resistant Depression［J］. JAMA Netw Open， 2020， 3（8）： e207434. doi:10.1001/jamanetworkopen.2020.7434 |
| 29 | JIANG J， ZHANG C， LI C， et al. Magnetic seizure therapy for treatment-resistant depression［J］. Cochrane Database Syst Rev， 2021， 6（6）： CD013528. doi:10.1002/14651858.cd013528.pub2 |
| 30 | LI H， CUI L， LI J， et al. Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression： a network meta-analysis of randomized controlled trials［J］. J Affect Disord 2021， 287： 115-124. doi:10.1016/j.jad.2021.03.019 |
| 31 | MILEV R V， GIACOBBE P， KENNEDY S H， et al. Canadian Network for Mood and Anxiety Treatments （CANMAT） 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder： Section 4. Neurostimulation Treatments［J］. Can J Psychiatry， 2016， 61（9）： 561-575. doi:10.1177/0706743716660033 |
| 32 | SONMEZ A I， CAMSARI D D， NANDAKUMAR A L， et al. Accelerated TMS for Depression： A systematic review and meta-analysis［J］. Psychiatry Res， 2019， 273： 770-781. doi:10.1016/j.psychres.2018.12.041 |
| 33 | RACHID F. Accelerated transcranial magnetic stimulation for the treatment of Patients with depression： A review［J］. Asian J Psychiatr， 2019， 40： 71-75. doi:10.1016/j.ajp.2019.02.003 |
| 34 | ROTH Y， HANLON C A， PELL G， et al. Real world efficacy and safety of various accelerated deep TMS protocols for major depression［J］. Psychiatry Res， 2023， 328： 115482. doi:10.1016/j.psychres.2023.115482 |
| 35 | KISHI T， SAKUMA K， MATSUDA Y， et al. Intermittent theta burst stimulation vs. high-frequency repetitive transcranial magnetic stimulation for major depressive disorder： A systematic review and meta-analysis［J］. Psychiatry Res， 2023， 328： 115452. doi:10.1016/j.psychres.2023.115452 |
| 36 | CHEN M H， CHENG C M， LI C T， et al. Comparative study of low-dose ketamine infusion and repetitive transcranial magnetic stimulation in treatment-resistant depression： A posthoc pooled analysis of two randomized， double-blind， placebo-controlled studies［J］. Psychiatry Res， 2022， 316： 114749. doi:10.1016/j.psychres.2022.114749 |
| 37 | BLUMBERGER D M， VILA-RODRIGUEZ F， WANG W， et al. A randomized sham controlled comparison of once vs twice-daily intermittent theta burst stimulation in depression： A Canadian rTMS treatment and biomarker network in depression （CARTBIND） study［J］. Brain Stimul， 2021， 14（6）： 1447-1455. doi:10.1016/j.brs.2021.09.003 |
| 38 | COLE E J， STIMPSON K H， BENTZLEY B S， et al. Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression［J］. Am J Psychiatry， 2020， 177（8）： 716-726. doi:10.1176/appi.ajp.2019.19070720 |
| 39 | 唐乃龙，陈怡环，王洋涛，等. 个体化靶向机器人技术辅助斯坦福加速智能神经调节疗法精准治疗伴自杀观念的抑郁症患者的初步研究［J］. 中华精神科杂志， 2022， 55（1）： 14-23. doi:10.3760/cma.j.cn113661-20210527-00173 |
| 40 | ELYAMANY O， LEICHT G， HERRMANN C S， et al. Transcranial alternating current stimulation （tACS）： from basic mechanisms towards first applications in psychiatry［J］. Eur Arch Psychiatry Clin Neurosci， 2021， 271（1）： 135-156. doi:10.1007/s00406-020-01209-9 |
| 41 | WANG H， WANG K， XUE Q， et al. Transcranial alternating current stimulation for treating depression： a randomized controlled trial［J］. Brain， 2022， 145（1）： 83-91. doi:10.1093/brain/awab252 |
| 42 | QASEM W AL， ABUBAKER M， KVA??áK E. Working Memory and Transcranial-Alternating Current Stimulation-State of the Art： Findings， Missing， and Challenges［J］. Front Psychol， 2022， 13： 822545. doi:10.3389/fpsyg.2022.822545 |
| 43 | GUERRA A， ASCI F， ZAMPOGNA A， et al. Gamma-transcranial alternating current stimulation and theta-burst stimulation： inter-subject variability and the role of BDNF［J］. Clin Neurophysiol， 2020， 131（11）： 2691-2699. doi:10.1016/j.clinph.2020.08.017 |
| 44 | WOODHAM R， RIMMER R M， MUTZ J， et al. Is tDCS a potential first line treatment for major depression？［J］. Int Rev Psychiatry， 2021， 33（3）： 250-265. doi:10.1080/09540261.2021.1879030 |
| 45 | NIKOLIN S， MOFFA A， RAZZA L， et al. Time-course of the tDCS antidepressant effect： An individual participant data meta-analysis［J］. Prog Neuropsychopharmacol Biol Psychiatry， 2023， 125： 110752. doi:10.1016/j.pnpbp.2023.110752 |
| 46 | BENNABI D， NICOLIER M， MONNIN J， et al. Pilot study of feasibility of the effect of treatment with tDCS in patients suffering from treatment-resistant depression treated with escitalopram［J］. Clin Neurophysiol， 2015， 126（6）： 1185-1189. doi:10.1016/j.clinph.2014.09.026 |
| 47 | PALM U， SCHILLER C， FINTESCU Z， et al. Transcranial direct current stimulation in treatment resistant depression： a randomized double-blind， placebo-controlled study［J］. Brain Stimul， 2012， 5（3）： 242-251. doi:10.1016/j.brs.2011.08.005 |
| 48 | MARTIN D M， TENG J Z， LO T Y， et al.Clinical pilot study of transcranial direct current stimulation combined with Cognitive Emotional Training for medication resistant depression［J］. J Affect Disord，2018，232：89-95. doi:10.1016/j.jad.2018.02.021 |
| 49 | HU Y Y， YANG G， LIANG X S， et al. Transcranial low-intensity ultrasound stimulation for treating central nervous system disorders： A promising therapeutic application［J］. Front Neurol， 2023， 14： 1117188. doi:10.3389/fneur.2023.1117188 |
| 50 | HUANG Y， ALKINS R， SCHWARTZ M L，et al. Opening the Blood-Brain Barrier with MR Imaging-guided Focused Ultrasound： Preclinical Testing on a Trans-Human Skull Porcine Model［J］.Radiology，2017，282（1）：123-130. doi:10.1148/radiol.2016152154 |
| 51 | CATTARINUSSI G， MOGHADDAM H S， AARABI M H， et al. White Matter Microstructure Associated with the Antidepressant Effects of Deep Brain Stimulation in Treatment-Resistant Depression： A Review of Diffusion Tensor Imaging Studies［J］. Int J Mol Sci， 2022， 23（23）： 15379. doi:10.3390/ijms232315379 |
| 52 | ZHU Z， HUBBARD E， GUO X， et al. A connectomic analysis of deep brain stimulation for treatment-resistant depression［J］. Brain Stimul， 2021， 14（5）： 1226-1233. doi:10.1016/j.brs.2021.08.010 |
| 53 | FIGEE M， RIVA-POSSE P， CHOI K S， et al. Deep Brain Stimulation for Depression［J］. Neurotherapeutics， 2022， 19（4）： 1229-1245. doi:10.1007/s13311-022-01270-3 |
| 54 | REIF-LEONHARD C， REIF A， BAUNE B T， et al. Vagus nerve stimulation for difficult to treat depression［J］. Der Nervenarzt， 2022， 93（9）： 921-930. doi:10.1007/s00115-022-01282-6 |
| 55 | AARONSON S T， SEARS P， RUVUNA F， et al. A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual： Comparison of Response， Remission， and Suicidality［J］. Am J Psychiatry， 2017， 174（7）： 640-648. doi:10.1176/appi.ajp.2017.16010034 |
| 56 | RUSH A J， MARANGELL L B， SACKEIM H A， et al. Vagus nerve stimulation for treatment-resistant depression： a randomized， controlled acute phase trial［J］. Biol Psychiatry， 2005， 58（5）： 347-354. doi:10.1016/j.biopsych.2005.05.025 |
| 57 | 周晶晶，贾圣陶，张晓华，等. 迷走神经刺激术治疗5例难治性抑郁症患者的疗效及安全性分析［J］. 神经疾病与精神卫生， 22022，22（3）： 172-176. |
| 58 | ARMOUR M， SMITH C A， WANG L Q， et al. Acupuncture for Depression： A Systematic Review and Meta-Analysis［J］. J Clin Med， 2019， 8（8）： 1140. doi:10.3390/jcm8081140 |
| 59 | XU G， LEI H， HUANG L， et al. The dose-effect association between acupuncture sessions and its effects on major depressive disorder： A meta-regression of randomized controlled trials［J］. J Affect Disord， 2022， 310： 318-327. doi:10.1016/j.jad.2022.04.155 |
| 60 | XU M M， GUO P， MA Q Y， et al. Can acupuncture enhance therapeutic effectiveness of antidepressants and reduce adverse drug reactions in patients with depression？ A systematic review and meta-analysis［J］. J Integr Med， 2022， 20（4）： 305-320. doi:10.1016/j.joim.2022.05.002 |
| 61 | CHEN B， WANG C C， LEE K H， et al. Efficacy and safety of acupuncture for depression： A systematic review and meta-analysis［J］. Res Nurs Health， 2023， 46（1）： 48-67. doi:10.1002/nur.22284 |
| 62 | SVERRE K T， NISSEN E R， FARVER-VESTERGAARD I， et al. Comparing the efficacy of mindfulness-based therapy and cognitive-behavioral therapy for depression in head-to-head randomized controlled trials： A systematic review and meta-analysis of equivalence［J］. Clin Psychol Rev， 2023， 100： 102234. doi:10.1016/j.cpr.2022.102234 |
| 63 | ZHANG B， FU W， GUO Y， et al. Effectiveness of mindfulness-based cognitive therapy against suicidal ideation in patients with depression： A systematic review and meta-analysis［J］. J Affect Disord， 2022， 319： 655-662. doi:10.1016/j.jad.2022.09.091 |
| 64 | LI X， LAPLANTE D P， PAQUIN V， et al. Effectiveness of cognitive behavioral therapy for perinatal maternal depression， anxiety and stress： A systematic review and meta-analysis of randomized controlled trials［J］. Clin Psychol Rev， 2022， 92： 102129. doi:10.1016/j.cpr.2022.102129 |
| 65 | GALIMA S V， VOGEL S R， KOWALSKI A W. Seasonal Affective Disorder： Common Questions and Answers［J］. Am Fam Physician， 2020， 102（11）： 668-672. |
| 66 | MITTER P， DE CRESCENZO F， YONG KEE K LOO， et al. Sleep deprivation as a treatment for major depressive episodes： A systematic review and meta-analysis［J］. Sleep Med Rev， 2022， 64： 101647. doi:10.1016/j.smrv.2022.101647 |
/
| 〈 |
|
〉 |